跳至主要内容
临床试验/NCT07332598
NCT07332598Enrolling By Invitation不适用

Mayo Clinic Precure - Prospective Study

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 100,000 人开始时间: 2026年1月19日最近更新:

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
Mayo Clinic
入组人数
100,000
试验地点
1
主要终点
Build a comprehensive, multi-omics and phenotype dataset

研究概览

简要总结

The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and environmental contributors to disease, 3) identify ways to stop disease advancement before it becomes serious or complex, and 4) identify potential targets for disease therapy.

Participants will be asked to:

  • collect biological samples,
  • download a mobile app,
  • collect speech (voice) recordings, and
  • complete surveys

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Registered Mayo Clinic patient
  • Able to provide informed written consent
  • Able to receive mail and packages within a United States (US) state
  • Able to collect and ship samples within a US state via FedEx for overnight delivery

排除标准

  • Active hematological cancer or history of a hematological cancer
  • Allogeneic Bone Marrow Transplant (autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)
  • Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)

研究组 & 干预措施

Suspected Genetic Predisposition or Multi-Omics Contribution

Patients with a diagnosis or phenotype with the potential for association with a genetic predisposition or Multi-Omics Contribution

Health Control

Patients with no diagnosis associated with a genetic predisposition or Multi-Omics Contribution.

结局指标

主要结局

Build a comprehensive, multi-omics and phenotype dataset

时间窗: Up to 5 years

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Konstantinos N. Lazaridis, M.D.

Executive Director, Center for Individualized Medicine

Mayo Clinic

研究点 (1)

Loading locations...

相似试验